Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Reproductive Health Market Research

Europe Male Infertility Market 2023-2030

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 117 Pages Triton Market Research July, 2023 TRTN18073104
Best Price Guarantee
Price from $1,500
Length 117 Pages
Publisher Triton Market Research
Published Date July, 2023
SKU TRTN18073104

Europe Male Infertility Market 2023-2030



MARKET OUTLOOK

Triton Market Research’s report that the male infertility market in Europe will display a compound annual growth rate of 4.59% in revenue during 2023-2030. Germany, Italy, the United Kingdom, Spain, France, Poland, and the Rest of Europe are considered in the region.

In France, the increasing prevalence of lifestyle-oriented diseases, rising stress levels, and higher smoking rates contribute to higher rates of male infertility. According to Macrotrends, the current fertility rate in 2023 stands at 1.848 births per woman, marking a slight decrease of 0.05% from 2022. Further, the International Cancer Genome Consortium estimates that around 70,000 new prostate cancer cases are detected yearly, resulting in 8,700 deaths annually. Hence, these factors elevate the demand for male infertility testing across the nation.

The Italian market is estimated to expand due to key factors such as increasing male infertility cases and lifestyle-related changes, including diet, pollution, stress, and obesity. Stress, anxiety, and health issues are also significant factors impacting the male infertility market. Further, prostate cancer is on the rise, which is anticipated to generate opportunities for the male infertility market.

COMPETITIVE OUTLOOK

The eminent firms in the male infertility market include EMD Serono Inc, Bayer AG, Sanofi SA, Zydus Lifesciences Limited, and Endo International Plc.


1. Europe Male Infertility Market - Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Male Infertility Market
2.2.1. Covid-19 Impact
2.2.2. Ukraine-russia War Impact
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Key Market Strategies
2.5.1. Collaborations
2.5.2. Product Launches
2.5.3. Mergers & Acquisitions
2.5.4. Business Divestitures & Expansions
2.6. Market Drivers
2.6.1. Prevalence Of Infertility
2.6.2. Use Of Assisted Reproductive Technologies
2.6.3. Technological Innovations And Advancements
2.7. Market Challenge
2.7.1. High Cost Of Treatment
2.8. Market Opportunities
2.8.1. Increasing Acceptance Of Minimally Invasive Surgeries
2.8.2. Growing Availability Of Infertility Treatment Drugs, Procedures, And Devices
2.8.3. Government Initiatives Toward Improving Reimbursement Policies
2.9. Analyst Perspective
3. Europe Male Infertility Market – By Test Type
3.1. Dna Fragmentation Technique
3.2. Oxidative Stress Analysis
3.3. Microscopic Examination
3.4. Sperm Agglutination
3.5. Computer-assisted Semen Analysis
3.6. Sperm Penetration Assay
3.7. Other Test Types
4. Europe Male Infertility Market – By Treatment
4.1. Assisted Reproductive Technology And Surgery
4.2. Medications
5. Europe Male Infertility Market – By Country Outlook
5.1. Country Analysis
5.1.1. United Kingdom
5.1.1.1. United Kingdom Male Infertility Market Forecast & Prospects
5.1.2. Germany
5.1.2.1. Germany Male Infertility Market Forecast & Prospects
5.1.3. France
5.1.3.1. France Male Infertility Market Forecast & Prospects
5.1.4. Italy
5.1.4.1. Italy Male Infertility Market Forecast & Prospects
5.1.5. Spain
5.1.5.1. Spain Male Infertility Market Forecast & Prospects
5.1.6. Poland
5.1.6.1. Poland Male Infertility Market Forecast & Prospects
5.1.7. Rest Of Europe
5.1.7.1. Rest Of Europe Male Infertility Market Forecast & Prospects
6. Competitive Landscape
6.1. Halotech Dna
6.1.1. Overview
6.1.2. Product Portfolio
6.2. Emd Serono Inc
6.2.1. Overview
6.2.2. Product Portfolio
6.2.3. Key Strengths
6.2.4. Key Challenges
6.3. Endo International Plc
6.3.1. Overview
6.3.2. Product Portfolio
6.3.3. Key Strengths
6.3.4. Key Challenges
6.4. Vitrolife
6.4.1. Overview
6.4.2. Product Portfolio
6.4.3. Key Strengths
6.4.4. Key Challenges
6.5. Bayer Ag
6.5.1. Overview
6.5.2. Product Portfolio
6.5.3. Key Strengths
6.5.4. Key Challenges
6.6. Aytu Biopharma
6.6.1. Overview
6.6.2. Product Portfolio
6.6.3. Key Strengths
6.6.4. Key Challenges
6.7. Zydus Lifesciences Limited
6.7.1. Overview
6.7.2. Product Portfolio
6.7.3. Key Strengths
6.7.4. Key Challenges
6.8. Cinnagen Co
6.8.1. Overview
6.8.2. Product Portfolio
6.8.3. Key Strengths
6.8.4. Key Challenges
6.9. Sanofi Sa
6.9.1. Overview
6.9.2. Product Portfolio
6.9.3. Key Strengths
6.9.4. Key Challenges
6.10. Laboratory Corporation Of America Holdings
6.10.1. Overview
6.10.2. Product Portfolio
6.10.3. Key Strengths
6.10.4. Key Challenges
7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.2. Sources Of Data
7.3. Research Methodology
Table List
Table 1: Europe Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 2: List Of Collaborations
Table 3: List Of Product Launches
Table 4: List Of Mergers & Acquisitions
Table 5: List Of Business Divestitures & Expansions
Table 6: Europe Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 7: Europe Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 8: Europe Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Figure List
Figure 1: Market Maturity Analysis
Figure 2: Europe Male Infertility Market, By Type, 2022 & 2030 (In %)
Figure 3: Europe Male Infertility Market, By Dna Fragmentation Technique, 2023-2030 (In $ Million)
Figure 4: Europe Male Infertility Market, By Oxidative Stress Analysis, 2023-2030 (In $ Million)
Figure 5: Europe Male Infertility Market, By Microscopic Examination, 2023-2030 (In $ Million)
Figure 6: Europe Male Infertility Market, By Sperm Agglutination, 2023-2030 (In $ Million)
Figure 7: Europe Male Infertility Market, By Computer-assisted Semen Analysis, 2023-2030 (In $ Million)
Figure 8: Europe Male Infertility Market, By Sperm Penetration Assay, 2023-2030 (In $ Million)
Figure 9: Europe Male Infertility Market, By Other Test Types, 2023-2030 (In $ Million)
Figure 10: Europe Male Infertility Market, By Treatment, 2022 & 2030 (In %)
Figure 11: Europe Male Infertility Market, By Assisted Reproductive Technology And Surgery, 2023-2030 (In $ Million)
Figure 12: Europe Male Infertility Market, By Medications, 2023-2030 (In $ Million)
Figure 13: Europe Male Infertility Market, By Country Outlook, 2022 & 2030 (In %)
Figure 14: United Kingdom Male Infertility Market 2023-2030 (In $ Million)
Figure 15: Germany Male Infertility Market 2023-2030 (In $ Million)
Figure 16: France Male Infertility Market 2023-2030 (In $ Million)
Figure 17: Italy Male Infertility Market 2023-2030 (In $ Million)
Figure 18: Spain Male Infertility Market 2023-2030 (In $ Million)
Figure 19: Poland Male Infertility Market 2023-2030 (In $ Million)
Figure 20: Rest Of Europe Male Infertility Market 2023-2030 (In $ Million)

$1,500
$2,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings